![Stephen Connelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Connelly
Gründer bei
EQUILLIUM, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Stephen Connelly is the founder of Equillium, Inc., founded in 2017, where the title held is President & Chief Scientific Officer.
Former jobs include Director-Business Development at aTyr Pharma, Inc. from 2014 to 2016, Senior Scientist at The Scripps Research Institute from 2012 to 2014, and Principal at BioMed Ventures.
Education history includes undergraduate and doctorate degrees from The University of Exeter and an MBA from Rady School of Management at UC San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EQUILLIUM, INC. 1.21% | 05.06.2026 | 762’025 ( 1.21% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Stephen Connelly
| Unternehmen | Position | Beginn |
|---|---|---|
| EQUILLIUM, INC. | Gründer | 16.03.2017 |
Ehemalige bekannte Positionen von Stephen Connelly
| Unternehmen | Position | Ende |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01.03.2016 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.03.2014 |
BioMed Ventures
 BioMed Ventures Investment ManagersFinance BioMed Ventures invests in companies located in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in early stage transactions. | Corporate Officer/Principal | - |
Ausbildung von Stephen Connelly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Exeter
 The University of Exeter Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rady School of Management at UC San Diego
 Rady School of Management at UC San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMed Ventures
BioMed Ventures Investment ManagersFinance BioMed Ventures invests in companies located in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in early stage transactions. | Finance |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
